ING GROEP NV - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
ING GROEP NV ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2019$316,000
-83.9%
6,000
-86.2%
0.01%
-84.2%
Q2 2018$1,965,000
-63.3%
43,483
-68.1%
0.04%
-57.3%
Q4 2017$5,358,000
+685.6%
136,175
+446.0%
0.09%
+584.6%
Q2 2017$682,000
-57.8%
24,942
-43.2%
0.01%
-55.2%
Q1 2017$1,618,00043,9200.03%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders